Evidence map›Paper›PMID 40092280›Full record

ArticleJournal of orthopaedic case reports2025

Primary Malignant Giant Cell Tumor of Bone with Metastasis: A Case Report and Literature Review.

Hazem Aboaid, John A deVries, Russell Gollard

Abstract readCase Reports
In one paragraph

Article in Journal of orthopaedic case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Hazem AboaidDepartment of Internal Medicine, Kirk Kerkorian School of Medicine at UNLV, Las Vegas, NV, USA.
John A deVriesDepartment of Orthopaedic Surgery, City of Hope, Duarte, CA, USA.
Russell GollardOptumCare Cancer Care, Las Vegas, NV, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Malignant giant cell tumor of bone (GCTB) is a very rare tumor, especially the primary type of it. We report a case of a young female who was diagnosed with a primary malignant giant cell tumor, in addition to a literature review of the previously reported cases. This case report aims to highlight the importance of high clinical suspicion and comprehensive workup to detect malignancy in giant cell tumors. We also review and add another case to the medical literature to help better understand the behavior of this rare tumor. Case Report: A 30-year-old African American female presented with left knee pain. Imaging showed a cystic bone lesion of the left proximal tibia, which was found to be consistent with a primary malignant giant cell tumor on biopsy. She started neoadjuvant chemotherapy (methotrexate + doxorubicin + cisplatin); however, she only tolerated one cycle, and then she underwent a radical resection of the left proximal tibia with endoprosthetic reconstruction. She had multiple hospitalizations later, and she was found to have significant pulmonary and spinal metastasis. Eventually, she decided to resume chemotherapy due to her worsening disease, and she completed four cycles of doxorubicin and cisplatin with a recent plan to switch to regorafenib given her refractory disease. Conclusion: Diagnosis of primary malignant GCTB can be very challenging. It is always important to seek an expert opinion given the rare nature of this tumor. Early detection is very important to establish the appropriate treatment.

Indexed as

Giant cell tumor of bonemalignantprimarysecondary

Identifiers

PMID40092280
PMCPMC11907131

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.